OTCMKTS:BNKL

Bionik Laboratories Stock Insider Trading

> Medical - Care Facilities

Buy BNKL

*Your capital is at risk

$0.0001

+0 (+0%)

At Close: Jul 31, 2026

Bionik Laboratories Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 13.22M and sold 9.99K BNKL shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	0
● Buy	13.22M shares
● Sell	9.99K shares
98% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 26, 2021 Buy	Common Stock, par value $0.001 per share P-Purchase	Gaston-dreyfus Remi	Director	135 560 Value: $45.9B
Mar 26, 2021 Buy	Common Stock, par value $0.001 per share P-Purchase	Gaston-dreyfus Remi Director	Director	135 560 Value: $0
Mar 26, 2021 Buy	Common Stock, par value $0.001 per share P-Purchase	Gaston-dreyfus Remi Director	Director	135 560 Value: $0
Mar 26, 2021 Buy	Common Stock, par value $0.001 per share P-Purchase	Gaston-dreyfus Remi	Director	135 560 Value: $45.9B
Mar 26, 2021 Buy	Common Stock, par value $0.001 per share P-Purchase	Auberton-herve Andre-jacques Chairman	CEO / President	95 149 Value: $24.3B
Mar 26, 2021 Buy	Common Stock, par value $0.001 per share P-Purchase	Auberton-herve Andre-jacques Chairman	CEO / President	95 149 Value: $24.3B
Nov 25, 2019 Buy	Common Stock C-Conversion	Gaston-dreyfus Remi	Director	4 997 Value: $0
Nov 25, 2019 Sell	Exchangeable Shares C-Conversion	Gaston-dreyfus Remi	Director	4 997 Value: $0
Nov 25, 2019 Sell	Exchangeable Shares C-Conversion	Gaston-dreyfus Remi	Director	4 997 Value: $0
Nov 25, 2019 Buy	Common Stock C-Conversion	Gaston-dreyfus Remi	Director	4 997 Value: $0
Sep 30, 2019 Buy	Common Stock C-Conversion	Gaston-dreyfus Remi	Director	76 225 Value: $518.3K
Sep 30, 2019 Buy	Common Stock C-Conversion	Gaston-dreyfus Remi	Director	76 225 Value: $518.3K
Sep 03, 2019 Buy	Stock Option (Right to Buy)	Wass Loren W. See Remarks	Officer	5 000 Value: $16.0K
Sep 03, 2019 Buy	Stock Option (Right to Buy)	Wass Loren W. See Remarks	Officer	5 000 Value: $16.0K
Aug 26, 2019 Buy	Common Stock P-Purchase	Gaston-dreyfus Remi	Director	106 358 Value: $399.9K
Aug 26, 2019 Buy	Common Stock P-Purchase	Gaston-dreyfus Remi	Director	106 358 Value: $399.9K
Jul 26, 2019 Buy	Employee Stock Option (right to buy) A-Award	Auberton-herve Andre-jacques Director	Director	115 759 Value: $415.6K
Jul 26, 2019 Buy	Employee Stock Option (right to buy) A-Award	Auberton-herve Andre-jacques Director	Director	115 759 Value: $415.6K
Jul 26, 2019 Buy	Employee Stock Option (right to buy) A-Award	Auberton-herve Andre-jacques Director	Director	115 759 Value: $415.6K
Jul 26, 2019 Buy	Employee Stock Option (right to buy) A-Award	Thevenon Audrey Director	Director	19 293 Value: $69.3K
Jul 26, 2019 Buy	Employee Stock Option (right to buy) A-Award	Malone Peter Gerald Director	Director	19 293 Value: $69.3K
Jul 26, 2019 Buy	Employee Stock Option (right to buy) A-Award	Matine Charles Director	Director	19 293 Value: $69.3K
Jul 26, 2019 Buy	Employee Stock Option (right to buy) A-Award	Martin Joseph R Director	Director	19 293 Value: $69.3K
Jul 26, 2019 Buy	Employee Stock Option (right to buy) A-Award	Gaston-dreyfus Remi Director	Director	115 759 Value: $415.6K
Jul 26, 2019 Buy	Employee Stock Option (right to buy) A-Award	Dusseux Eric Michel Chief Executive Officer	CEO / President	115 759 Value: $415.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BIONIK LABORATORIES CORP.

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy...

Read Full Profile Here